Related Experiment Videos
New and improved glucocorticoid receptor ligands
Jeffrey N Miner1, Mei Hua Hong, Andrés Negro-Vilar
1Department of Molecular and Cell Biology, Ligand Pharmaceuticals, San Diego, CA 92121, USA.
Expert Opinion on Investigational Drugs
|November 26, 2005
Summary
Glucocorticoids combat inflammation but cause bone loss (osteoporosis). Identifying new glucocorticoid receptor actions may lead to safer steroid therapies with similar efficacy for patients.
Area of Science:
- Pharmacology
- Endocrinology
- Bone Biology
Background:
- Glucocorticoids are widely used for their anti-inflammatory, antiproliferative, and immunomodulatory effects.
- Long-term glucocorticoid therapy can lead to severe side effects, including osteoporosis and increased fracture risk.
- Glucocorticoids induce bone damage via multiple mechanisms, necessitating research into safer alternatives.
Purpose of the Study:
- To explore novel glucocorticoids with reduced side effects.
- To investigate new mechanisms of action for the glucocorticoid receptor.
- To identify safer therapeutic options for conditions requiring steroid treatment.
Main Methods:
- Review of existing literature on glucocorticoid mechanisms and side effects.
- Analysis of glucocorticoid receptor pathways.
- Exploration of emerging therapeutic strategies targeting glucocorticoid action.
Main Results:
- Glucocorticoids exert detrimental effects on bone through various pathways.
- Understanding the glucocorticoid receptor's diverse functions is key to developing targeted therapies.
- New therapeutic avenues are emerging based on novel mechanistic insights.
Conclusions:
- Developing safer glucocorticoids is crucial due to the debilitating side effects of current therapies, particularly osteoporosis.
- Further research into glucocorticoid receptor mechanisms can facilitate the discovery of novel, safer anti-inflammatory drugs.
- The identification of new therapeutic targets holds promise for more effective and tolerable steroid-based treatments.